At a glance
- Originator Wyeth
- Class Anxiolytics
- Mechanism of Action 5-HT1A serotonin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 28 Sep 2006 Discontinued - Preclinical for Anxiety disorders in USA (unspecified route)
- 27 Mar 2002 American Home Products and its subsidiaries Wyeth-Ayerst and Wyeth Lederle are both now called Wyeth
- 09 Oct 2000 Profile reviewed but no significant changes made